DE60121953D1 - Herstellungsverfahren von arzneizubereitungen - Google Patents

Herstellungsverfahren von arzneizubereitungen

Info

Publication number
DE60121953D1
DE60121953D1 DE60121953T DE60121953T DE60121953D1 DE 60121953 D1 DE60121953 D1 DE 60121953D1 DE 60121953 T DE60121953 T DE 60121953T DE 60121953 T DE60121953 T DE 60121953T DE 60121953 D1 DE60121953 D1 DE 60121953D1
Authority
DE
Germany
Prior art keywords
medicine preparations
manufacturing medicine
manufacturing
preparations
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121953T
Other languages
English (en)
Other versions
DE60121953T2 (de
Inventor
Patrick Busson
Marco Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121953(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60121953D1 publication Critical patent/DE60121953D1/de
Publication of DE60121953T2 publication Critical patent/DE60121953T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60121953T 2000-06-27 2001-06-18 Herstellungsverfahren von arzneizubereitungen Expired - Lifetime DE60121953T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27
EP00113535 2000-06-27
PCT/EP2001/006834 WO2002000201A2 (en) 2000-06-27 2001-06-18 Method for preparing a composition

Publications (2)

Publication Number Publication Date
DE60121953D1 true DE60121953D1 (de) 2006-09-14
DE60121953T2 DE60121953T2 (de) 2007-03-08

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121953T Expired - Lifetime DE60121953T2 (de) 2000-06-27 2001-06-18 Herstellungsverfahren von arzneizubereitungen

Country Status (38)

Country Link
US (3) US6534087B2 (de)
EP (1) EP1296656B1 (de)
JP (2) JP4149803B2 (de)
KR (1) KR100557845B1 (de)
CN (1) CN1236764C (de)
AR (1) AR029278A1 (de)
AT (1) ATE334662T1 (de)
AU (2) AU8184601A (de)
BR (1) BRPI0112014B1 (de)
CA (1) CA2411153C (de)
CY (1) CY1105714T1 (de)
CZ (1) CZ301813B6 (de)
DE (1) DE60121953T2 (de)
DK (1) DK1296656T3 (de)
EC (1) ECSP024401A (de)
EG (1) EG24141A (de)
ES (1) ES2269441T3 (de)
HK (1) HK1058314A1 (de)
HR (1) HRP20021009B1 (de)
HU (1) HU229550B1 (de)
IL (2) IL153282A0 (de)
JO (1) JO2247B1 (de)
MA (1) MA26922A1 (de)
ME (1) MEP90608A (de)
MX (1) MXPA02012583A (de)
MY (1) MY129798A (de)
NO (1) NO332181B1 (de)
NZ (1) NZ523024A (de)
PE (1) PE20020101A1 (de)
PL (1) PL203804B1 (de)
PT (1) PT1296656E (de)
RU (1) RU2244542C2 (de)
SI (1) SI1296656T1 (de)
TW (1) TWI278325B (de)
UY (1) UY26799A1 (de)
WO (1) WO2002000201A2 (de)
YU (1) YU96602A (de)
ZA (1) ZA200209649B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
RU2244542C2 (ru) * 2000-06-27 2005-01-20 Ф.Хоффманн-Ля Рош Аг Способ приготовления композиции
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
MXPA04010371A (es) * 2002-04-26 2005-02-03 Hoffmann La Roche Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan.
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
ES2552936T3 (es) * 2003-12-12 2015-12-03 Otic Pharma Ltd. Composiciones para el tratamiento del desordenes en el oído y métodos para el uso de los mismos
EP1737405A2 (de) * 2004-04-06 2007-01-03 RPG Life Sciences Limited Oral lösliche und schmelzbare sowie wasserlösliche abgabeformulierung
US7398161B2 (en) * 2004-09-15 2008-07-08 Banyu Pharmaceutical Co., Ltd. Sampling method and sampling device, and logD measuring method and logD measuring system
CA2593728A1 (en) * 2004-12-31 2006-07-13 Mikhail Yurievich Gotovskiy Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20070060610A1 (en) * 2005-06-16 2007-03-15 Wempe Michael F Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
WO2007046102A2 (en) 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
JP2009530614A (ja) 2006-03-16 2009-08-27 デューク ユニバーシティ フーリエ領域光コヒーレンス・トモグラフィーに基づく実時間直角位相投影を実行するための方法、システム及びコンピュータプログラム製品
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (de) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmazeutische Zusammensetzung enthaltend Tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
EP2117354B1 (de) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. Trockenes nahrungsmittel mit lebendem probiotikum
EP2157970A1 (de) * 2007-05-18 2010-03-03 Tti Ellebeau, Inc. Transdermale freisetzungsvorrichtungen für verbesserte freisetzung eines wirkstoffes durch eine biologische schnittstelle
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
EP2219614A1 (de) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmazeutische zusammensetzung von orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
EP2410996B1 (de) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
CN102459568A (zh) 2009-05-26 2012-05-16 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
WO2011040956A1 (en) * 2009-09-29 2011-04-07 Michael Burnet Novel pesticide formulations
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
CA2785815C (en) 2010-01-28 2018-04-24 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
JP5974891B2 (ja) * 2010-04-07 2016-08-23 三菱瓦斯化学株式会社 保存安定性に優れたｓ−アデノシル−ｌ−メチオニン含有乾燥酵母組成物及びその製造方法
JP5727611B2 (ja) 2010-08-13 2015-06-03 アドバンスド バイオニュートリション コーポレイション 生体物質用の乾燥貯蔵安定化組成物
CN103228266B (zh) * 2010-10-29 2017-11-14 健康科学西部大学 三元混合物制剂
EP2680815B1 (de) 2011-03-01 2016-08-17 The Procter and Gamble Company Poröser sich auflösender fester formkörper für gesundheitspflegeanwendungen
RU2666601C2 (ru) 2012-03-23 2018-09-11 Эдванст Бионутришн Корп. Стабилизирующая композиция для биологических материалов
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
JP6839666B2 (ja) 2015-06-25 2021-03-10 ネイティブ マイクロビアルズ， インコーポレイテッド 複雑な異種群集由来微生物株の解析、機能的な関係及びそれらの相互作用の予測及び同定、ならびにそれに基づく微生物アンサンブルの選択及び合成のための方法、装置、及びシステム
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
JP2020504620A (ja) 2016-12-28 2020-02-13 アスカス バイオサイエンシーズ， インコーポレイテッド 複雑な不均一コミュニティの完全微生物株の解析、その機能的関連性及び相互作用の決定、ならびにそれに基づく生物反応性の改変剤の同定及び合成、のための方法、装置、及びシステム
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
EP0553777B1 (de) 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
CN103772231B (zh) 1995-02-27 2016-02-03 吉里德科学公司 新颖化合物，其合成方法及治疗用途
DE10299052I1 (de) 1995-02-27 2003-05-22 Gilead Sciences Inc Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
WO1997038679A2 (en) * 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
BR9713258A (pt) * 1996-10-14 2000-03-28 Hoffmann La Roche Processo para a fabricação de uma preparação pulverosa
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6299906B1 (en) * 1998-04-09 2001-10-09 Hoffmann-La Roche Inc. Process for making submicron particles
KR20010079635A (ko) 1998-08-14 2001-08-22 프리돌린 클라우스너, 롤란드 비. 보레르 리파아제 저해제를 함유하는 약학 조성물
DE69916288T2 (de) 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ATE400252T1 (de) 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
RU2244542C2 (ru) * 2000-06-27 2005-01-20 Ф.Хоффманн-Ля Рош Аг Способ приготовления композиции

Also Published As

Publication number Publication date
US20020018812A1 (en) 2002-02-14
KR100557845B1 (ko) 2006-03-10
MA26922A1 (fr) 2004-12-20
CA2411153C (en) 2007-01-30
JP2004501184A (ja) 2004-01-15
MY129798A (en) 2007-04-30
JP2007302683A (ja) 2007-11-22
EP1296656B1 (de) 2006-08-02
CN1438880A (zh) 2003-08-27
IL153282A0 (en) 2003-07-06
HRP20021009B1 (en) 2011-07-31
ATE334662T1 (de) 2006-08-15
DE60121953T2 (de) 2007-03-08
HRP20021009A2 (en) 2004-02-29
US20030039614A1 (en) 2003-02-27
NO20026197D0 (no) 2002-12-23
KR20030023880A (ko) 2003-03-20
MXPA02012583A (es) 2003-04-10
CA2411153A1 (en) 2002-01-03
WO2002000201A2 (en) 2002-01-03
HU229550B1 (en) 2014-01-28
HUP0302060A3 (en) 2006-07-28
PL203804B1 (pl) 2009-11-30
DK1296656T3 (da) 2006-11-27
PE20020101A1 (es) 2002-02-12
EG24141A (en) 2008-08-06
WO2002000201A3 (en) 2002-04-18
NZ523024A (en) 2004-08-27
ES2269441T3 (es) 2007-04-01
HK1058314A1 (en) 2004-05-14
CZ301813B6 (cs) 2010-06-30
NO20026197L (no) 2002-12-23
CY1105714T1 (el) 2010-12-22
PL365803A1 (en) 2005-01-10
JO2247B1 (en) 2004-10-07
AU2001281846B2 (en) 2006-04-27
IL153282A (en) 2008-03-20
AR029278A1 (es) 2003-06-18
PT1296656E (pt) 2006-12-29
CZ2003212A3 (cs) 2003-06-18
HUP0302060A2 (hu) 2003-09-29
US20060134205A1 (en) 2006-06-22
ME00672B (me) 2011-12-20
US6534087B2 (en) 2003-03-18
US7074431B2 (en) 2006-07-11
RU2244542C2 (ru) 2005-01-20
EP1296656A2 (de) 2003-04-02
ECSP024401A (es) 2003-02-06
SI1296656T1 (sl) 2006-12-31
BRPI0112014B1 (pt) 2016-09-13
CN1236764C (zh) 2006-01-18
MEP90608A (en) 2011-12-20
NO332181B1 (no) 2012-07-16
ZA200209649B (en) 2004-03-10
YU96602A (sh) 2005-03-15
BR0112014A (pt) 2003-05-13
JP4149803B2 (ja) 2008-09-17
AU8184601A (en) 2002-01-08
UY26799A1 (es) 2001-12-28
TWI278325B (en) 2007-04-11

Similar Documents

Publication Publication Date Title
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
NO20033556D0 (no) Farmasöytiske preparater
NO20071303L (no) Farmasoytiske preparater
FR14C0080I2 (fr) Methode d'administration d'un anticorps
NO20035426L (no) Fremgangsmate ved administrering av anti-TNF-D-antistoff
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE50104433D1 (de) Desodorierende Zubereitungen
NO20040353L (no) Ny terapeutsk metode
ID30187A (id) Dongkrak jenis pantagraf
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
NO20044916L (no) Preparater av sulfinylacetamid
DE60126814D1 (de) Inhalation von stickoxid
ATE355062T1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
DE50003755D1 (de) Satz von schmuckstücken
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
DE60232290D1 (de) Kontrollierte Auflösung von Wirkstoffen
DE60142051D1 (de) Herstellung von perfluorolefinen
FI20000194A0 (fi) Menetelmä kaupankäynnissä
DE60103685D1 (de) Behandlung von Poriomania
EE200200653A (et) alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid
DE60007360T2 (de) Amorphe modifikation von torasemid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition